FEMYライブシグナル | Getagraph.comで利益を最大化

Live Chart Being Loaded With Signals

Commentary (30 4月 2024 @ 01:40):

Stats
本日の出来高	53 028.00
平均出来高	743 111
時価総額	28.29M
EPS	$0 ( 2024-04-04 )
次の収益日	( $-0.220 ) 2024-05-09
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-1.380
ATR14	$0.0140 (1.09%)

Insider Trading

Date	Person	Action	Amount	type
2024-02-12	Spector Richard D.	Buy	100 000	Stock Option (Right to Buy)
2024-02-12	Spector Richard D.	Buy	0
2024-02-01	Currie Daniel Scott	Buy	61 900	Stock Option (Right to Buy)
2024-02-01	Elefant Dov	Buy	84 000	Stock Option (Right to Buy)
2024-02-01	Thomas Christine E	Buy	32 600	Stock Option (Right to Buy)

INSIDER POWER
-78.94
Last 82 transactions
Buy: 6 908 475 \| Sell: 19 734 221

ボリューム相関

長: -0.27 (neutral)

短: -0.79 (moderate negative)

Signal:(47.57) Neutral

Femasys Inc. 相関

10 最も正の相関
RMRM	0.863
NTEC	0.862
SQBG	0.806

10 最も負の相関
NETE	-0.826

知っていましたか？

相関は、2つの変数間の関係を説明する統計的指標です。相関係数は-1から1までの値を取り、-1は完全な負の相関（1つの変数が増加すると、もう一方は減少する）、1は完全な正の相関（1つの変数が増加すると、もう一方も増加する）、0は相関がないことを示します（変数間に関係がない）。

相関は、株式だけでなく、どの2つの変数間の関係にも適用できます。これは、金融、経済学、心理学などの分野で一般的に使用されています。

Femasys Inc. 相関 - 通貨/商品

-0.33
( neutral )

-0.40
( neutral )

0.00
( neutral )

-0.29
( neutral )

0.87
( strong )

0.33
( neutral )

Femasys Inc. 財務諸表

Annual	2023
収益:	$1.07M
総利益:	$-216 084 (-20.16 %)
EPS:	$-0.930

FY	2023
収益:	$1.07M
総利益:	$-216 084 (-20.16 %)
EPS:	$-0.930

FY	2022
収益:	$1.21M
総利益:	$764 280 (63.36 %)
EPS:	$-0.970

FY	2021
収益:	$1.18M
総利益:	$809 305 (68.60 %)
EPS:	$-0.831

Financial Reports:

No articles found.

Femasys Inc.

Femasys Inc., a biomedical company, focuses on women's healthcare market in the United States. The company develops permanent birth control solutions, such as FemBloc and FemChec; FemaSeed, an artificial insemination solution; FemCerv, a biopsy device for endocervical curettage; and FemEMB, a product candidate for endometrial sampling in support of uterine cancer detection testing. It also commercializes FemVue saline-air device in the United States, Europe, Canada, Japan, and internationally. The company offers its infertility products to obstetrics-gynecological physicians, related healthcare professionals, women's healthcare provider organizations, and reproductive endocrinologists. In addition, it provides non-surgical product technologies. Femasys Inc. was incorporated in 2004 and is based in Suwanee, Georgia.